These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6109787)

  • 1. Renal effects of beta-adrenoceptor blockade.
    Weber MA; Drayer JI
    Kidney Int; 1980 Nov; 18(5):686-99. PubMed ID: 6109787
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 4. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(39):1239-41. PubMed ID: 241073
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-Adrenoceptor blocking drugs and hypertension.
    Buckingham RE; Hamilton TC
    Gen Pharmacol; 1979; 10(1):1-13. PubMed ID: 33100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pindolol on renal function.
    Wainer E; Boner G; Rosenfeld JB
    Clin Pharmacol Ther; 1980 Nov; 28(5):575-80. PubMed ID: 7002425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
    Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the pA2 of various beta blocking agents].
    Spach MO; Miesch F; Schwartz J
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3221-2. PubMed ID: 3766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL; Levin DC; Manion CV
    Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect.
    van den Meiracker AH; Man in 't Veld AJ; Ritsema van Eck HJ; Schalekamp MA
    Am Heart J; 1986 Aug; 112(2):368-74. PubMed ID: 2874735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal effects of beta-blockers.
    Zech P; Pozet N; Labeeuw M; Laville M; Hadj-Aissa A; Arkouche W; Poncet JF
    Am J Nephrol; 1986; 6 Suppl 2():15-9. PubMed ID: 2879466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor-blocking agents in the management of hypertension.
    Prichard BN
    Cardiology; 1979; 64 Suppl 1():44-87. PubMed ID: 42488
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs.
    Kantelip JP; Duchene-Marullaz P; Delaigue-Fabry R; Eschalier A
    Br J Clin Pharmacol; 1982; 13(Suppl 2):159S-166S. PubMed ID: 6125165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.